Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin vs Hydrocortisone for PDPH
NCT03910088Phase 4Completed
- Sponsor
- Cairo University
- Start
- Apr 2019
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pregabalin and hydrocortisone in post-dural puncture headache (PDPH) (3 arms), sponsored by Cairo University. Primary endpoint: Assessment of pain using Visual Analogue Scale at 48 hours. Started Apr 2019; status: completed.
02
Drugs
pregabalinhydrocortisone
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT03910088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03910088.